American Century Companies Inc. boosted its stake in Surgery Partners, Inc. (NASDAQ:SGRY – Free Report) by 1.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 424,845 shares of the company’s stock after purchasing an additional 4,321 shares during the period. American Century Companies Inc. owned about 0.34% of Surgery Partners worth $14,571,000 at the end of the most recent quarter.
A number of other hedge funds have also recently added to or reduced their stakes in the stock. Raymond James & Associates lifted its stake in shares of Surgery Partners by 7.9% in the 1st quarter. Raymond James & Associates now owns 37,700 shares of the company’s stock valued at $2,075,000 after acquiring an additional 2,758 shares during the last quarter. Bank of New York Mellon Corp grew its holdings in shares of Surgery Partners by 0.7% during the first quarter. Bank of New York Mellon Corp now owns 137,662 shares of the company’s stock worth $7,578,000 after purchasing an additional 900 shares during the last quarter. PNC Financial Services Group Inc. grew its holdings in shares of Surgery Partners by 34.7% during the first quarter. PNC Financial Services Group Inc. now owns 1,195 shares of the company’s stock worth $66,000 after purchasing an additional 308 shares during the last quarter. MetLife Investment Management LLC increased its stake in shares of Surgery Partners by 54.2% in the first quarter. MetLife Investment Management LLC now owns 18,141 shares of the company’s stock valued at $999,000 after buying an additional 6,374 shares during the period. Finally, Panagora Asset Management Inc. bought a new position in Surgery Partners in the 1st quarter valued at approximately $851,000.
Surgery Partners Trading Up 3.1 %
NASDAQ:SGRY opened at $37.37 on Friday. Surgery Partners, Inc. has a 12 month low of $20.46 and a 12 month high of $45.79. The company has a current ratio of 1.77, a quick ratio of 1.61 and a debt-to-equity ratio of 0.84. The stock has a market capitalization of $4.73 billion, a price-to-earnings ratio of -66.73 and a beta of 2.73. The firm has a fifty day simple moving average of $38.70 and a two-hundred day simple moving average of $36.90.
Insider Buying and Selling at Surgery Partners
In other news, CEO Jason Eric Evans sold 1,892 shares of the company’s stock in a transaction that occurred on Thursday, June 29th. The stock was sold at an average price of $45.10, for a total transaction of $85,329.20. Following the transaction, the chief executive officer now directly owns 424,898 shares of the company’s stock, valued at $19,162,899.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 2.60% of the company’s stock.
Analyst Ratings Changes
Several equities analysts have recently issued reports on the stock. Barclays dropped their price target on shares of Surgery Partners from $56.00 to $51.00 and set an “overweight” rating for the company in a research note on Wednesday, August 2nd. Mizuho upped their price target on Surgery Partners from $48.00 to $50.00 in a research report on Tuesday, July 11th. StockNews.com initiated coverage on Surgery Partners in a research report on Thursday, August 17th. They set a “hold” rating for the company. Bank of America upgraded Surgery Partners from a “neutral” rating to a “buy” rating and upped their target price for the company from $42.00 to $45.00 in a report on Friday, June 2nd. Finally, Benchmark restated a “buy” rating and set a $50.00 price target on shares of Surgery Partners in a report on Wednesday, August 2nd. Two analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. According to data from MarketBeat, Surgery Partners currently has a consensus rating of “Moderate Buy” and a consensus target price of $44.09.
View Our Latest Analysis on Surgery Partners
About Surgery Partners
Surgery Partners, Inc, through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.
Read More
- Five stocks we like better than Surgery Partners
- Compound Interest and Why It Matters When Investing
- 2 Stocks That Doubled EPS Estimates and Flashing Buy Signals
- Insider Trades May Not Tell You What You Think
- Toyota vs Tesla: The Tortoise And The Hare Race Has A New Meaning
- What is the Dow Jones Industrial Average (DJIA)?
- 5 Critical Takeaways From MongoDB’s Q2 Results for AI Investors
Want to see what other hedge funds are holding SGRY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Surgery Partners, Inc. (NASDAQ:SGRY – Free Report).
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.
